menu
    • menu

    Company profile for KIYATEC

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    PMC Isochem is your partner for smart CDMOs of Intermediates, APIs, & excipients & a catalog of Intermediates & Generic APIs.

    Virtual Booth

    Contact Supplier

    Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    We leverage our proprietary ex vivo 3D cell culture technology platforms to accurately model and predict response to approved and investigational cancer drugs targeting a spectrum of solid tumors. Drug Development Services: We work with leading biopharmaceutical companies to unlock response dynamics (ex vivo efficacy) for their investigational cancer drug candidates in preclinical testing and subsequent clinical trials. ...
    We leverage our proprietary ex vivo 3D cell culture technology platforms to accurately model and predict response to approved and investigational cancer drugs targeting a spectrum of solid tumors. Drug Development Services: We work with leading biopharmaceutical companies to unlock response dynamics (ex vivo efficacy) for their investigational cancer drug candidates in preclinical testing and subsequent clinical trials. Clinical Testing Services (CLIA-certified laboratory): In 2019 we published of our assay’s analytical validation and clinical evidence of its predictive performance.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    KIYATECUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    900-B West Faris Road Greenville, SC 29605
    Telephone
    Telephone
    864-502-2013
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.kiyatec.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    BPI Europe

    BPI Europe

    Not Confirmed

    envelop Contact Supplier

    BPI Europe

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Kiyatec Gains MBD Investment to Boost U.S. Expansion
    Kiyatec Gains MBD Investment to Boost U.S. Expansion

    13 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251113713468/en/Kiyatec-Secures-Strategic-Investment-from-South-Korean-Partner-MBD-to-Accelerate-U.S.-Commercial-Expansion

    BUSINESSWIRE
    13 Nov 2025
    Share Share
    Kiyatec Publishes Study On 3D Predict™ Glioma In HGG Patients
    Kiyatec Publishes Study On 3D Predict™ Glioma In HGG Patients

    29 Aug 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240829571586/en

    BUSINESSWIRE
    29 Aug 2024
    Share Share
    Kiyatec Appoints Eric Perreault as New CEO to Lead Strategic Expansion
    Kiyatec Appoints Eric Perreault as New CEO to Lead Strategic Expansion

    04 Jan 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240104133912/en

    BUSINESSWIRE
    04 Jan 2024
    Share Share
    Kiyatec strengthens its leadership position with the addition of Mark Capone
    Kiyatec strengthens its leadership position with the addition of Mark Capone

    21 Nov 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20231121720316/en

    BUSINESSWIRE
    21 Nov 2023
    Share Share
    Kiyatec Appoints Eric Perreault to President and Tessa DesRochers CSO
    Kiyatec Appoints Eric Perreault to President and Tessa DesRochers CSO

    01 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230801566993/en

    BUSINESSWIRE
    01 Aug 2023
    Share Share
    Kiyatec & XenoSTART formally announce a agreement to help reduce drug devp costs
    Kiyatec & XenoSTART formally announce a agreement to help reduce drug devp costs

    29 Jun 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230629124288/en

    BUSINESSWIRE
    29 Jun 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search